Unified Patents, Inc. v. President and Fellows of Harvard College

I'll research this case before drafting. Note upfront: the metadata describes an IPR proceeding, not a district court litigation, so I'll verify the actual posture carefully.

Important discrepancy surfacing: docket records list Hamamatsu Corporation as petitioner in IPR2017-00909, not Unified Patents. Let me investigate both possibilities.

Now let me dig into the Board's reasoning and check whether Unified Patents had any separate involvement.

⚠️ Correction to the case metadata before anything else

The caption given to me — Unified Patents, Inc. v. President and Fellows of Harvard College — does not match the PTAB record. IPR2017-00909 was filed by Hamamatsu Corporation, not Unified Patents. Every primary document I retrieved says so: the petition itself (Paper 2), Harvard's power of attorney and mandatory notice (Papers 3–4), the Board's institution decision (Paper 7), and the National Law Review PTAB filing report of Feb. 16, 2017, which lists "Petitioner – HAMAMATSU CORPORATION." I could not find any Unified Patents petition against the '467 patent, and I also found no evidence that Unified was a real party in interest here. I've written the overview against the verified docket; if you need the caption to read "Unified Patents," that entry should be corrected in your database rather than repeated. (The rest of the metadata — case number, patent number, filing date, and the "not instituted / denied on the merits" status — checks out.)

---

Parties and technology. This is not an infringement litigation; it is a PTAB inter partes review of a single patent, with the real fight playing out in a parallel district court case. The petitioner, Hamamatsu Corporation, is the New Jersey-based North American marketing and sales subsidiary of Hamamatsu Photonics K.K., a Japanese photonics manufacturer (founded 1953) that makes silicon photodiodes, avalanche photodiodes, CCD/CMOS image sensors, and spectroscopy equipment; the petition named HPK and Photonics Management Corp. as real parties in interest. The patent owner, President and Fellows of Harvard College, holds the patent, but the operative commercial party is SiOnyx, LLC, the exclusive licensee, which Harvard identified as an RPI in its mandatory notice. SiOnyx was founded in 2006 by Harvard physicist Eric Mazur and his former doctoral student James Carey to commercialize "black silicon" — silicon whose surface is microstructured by femtosecond-laser irradiation in a dopant-bearing atmosphere, producing near-unity sub-bandgap absorption and dramatically improved near-infrared responsivity. The accused products in the underlying case were Hamamatsu's laser-textured photodiodes, APDs, and CCD sensors, which SiOnyx and Harvard alleged were built on confidential information SiOnyx disclosed to HPK under a 2007 NDA.

The patent and the grounds. Only one patent was at issue in the IPR: U.S. 8,080,467, "Silicon-Based Visible and Near-Infrared Optoelectric Devices" (issued Dec. 20, 2011; inventors Carey and Mazur). In one line: it claims silicon photodetectors made by a two-step process — laser-texturing a silicon surface in a sulfur/dopant ambient, then annealing — that exhibit enhanced visible-to-IR absorption and responsivity. Hamamatsu challenged claims 1–3 and 6–8 on four obviousness grounds: the Wu Thesis (a 2000 Harvard physics thesis by Claudia Wu, "Femtosecond laser-gas-solid interactions") or the Wu Article (Wu et al., Appl. Phys. Lett. 78(13), 2001, "Near-unity below-band-gap absorption by microstructured silicon"), each combined with Gibbons (a 1972 Proc. IEEE review of ion-implantation damage and annealing), and claim 3 additionally in view of Carey (1989, gas immersion laser doping). Notably, the closest prior art was the patentee's own university lab's earlier published work. Hamamatsu argued the claims' priority date was September 24, 2004 (the CIP filing) rather than the 2001 provisional, a dispute that ran through the petition and the preliminary response. Harvard's June 12, 2017 preliminary response argued there was no articulated motivation to anneal Wu's spiked samples and no reasonable expectation of success, invoking KSR and Intelligent Bio-Systems.

Procedural posture and why it matters. The petition was filed February 15, 2017; the Board accorded a filing date on March 10, 2017; Harvard responded June 12, 2017; and on September 6, 2017 a panel of APJs Joni Y. Chang, Jennifer S. Bisk, and Jacqueline T. Harlow (Harlow authoring) issued a Decision Denying Institution under 37 C.F.R. § 42.108, finding no reasonable likelihood of prevailing on any challenged claim, so no final written decision ever issued. Hamamatsu's request for rehearing (Oct. 6, 2017) was denied September 4, 2019 (Paper 9), and the $14,000 post-institution fees were refunded in October 2019 (Paper 11). Because § 314(a) institution determinations are non-appealable under § 314(d), the denial was the end of the road at the PTAB. The case is notable on several axes. First, it is a rare university patent that survived an IPR and was then enforced to judgment: in SiOnyx, LLC v. Hamamatsu Photonics K.K., No. 1:15-cv-13488-FDS (D. Mass., Judge F. Dennis Saylor IV), a jury found willful infringement of the '467 patent but awarded $0 in patent damages, plus NDA breach and unjust-enrichment damages, and the court granted a permanent injunction — affirmed in SiOnyx, LLC v. Hamamatsu Photonics K.K., 981 F.3d 1339 (Fed. Cir. Dec. 7, 2020), which also upheld an order compelling Hamamatsu to assign its own U.S. black-silicon patents to SiOnyx and reversed on foreign-patent ownership. Second, the case sits at the intersection of trade-secret and patent law: the petitioner's own patent portfolio became the remedy for the breach, and the IPR was a defensive move in a case it was losing on contract grounds. Third, it illustrates that an NDA-origin startup-versus-major-manufacturer dispute can hinge on the patentee's own pre-filing academic publications — and here the patentee won anyway. Fourth, it is not an NPE/PAE assertion pattern (neither Harvard nor SiOnyx is a non-practicing entity in the classic sense, and SiOnyx made competing CMOS sensors), so any framing of this docket as a "Unified Patents NPE challenge" would be doubly wrong.

Sourcing caveats. (1) The petitioner-name discrepancy described above is the most important item to resolve on your end. (2) I confirmed the outcome and identity of the decision but could not retrieve the full text of the Board's substantive reasoning; my description of the disputed issues comes from the petition's table of contents and Harvard's preliminary response rather than from a verified quotation of the decision. (3) Counsel of record: Panitch Schwarze Belisario & Nadel (John D. Simmons, Stephen E. Murray, Keith A. Jones) for Hamamatsu; Pepper Hamilton (Thomas J. Engellenner, Reza Mollaaghababa) for Harvard. (4) A Panitch firm announcement references a companion PTAB win invalidating claims of Harvard's '446 patent in the same litigation; I did not verify that proceeding's case number, so treat it as unconfirmed.

I'll research this proceeding and its context before writing.

Key finding: the docket records show the petitioner as Hamamatsu Corporation, and there's a parallel district court case. Let me dig into both.

Threshold note: two corrections to the case framing before the chronology

1. This was not an infringement litigation. IPR2017-00909 is an AIA inter partes review at the PTAB. There was no complaint, answer, counterclaim, Markman order, trial, or verdict in this proceeding. The infringement case that generated the IPR is SiOnyx, LLC et al. v. Hamamatsu Photonics K.K. et al., No. 1:15-cv-13488-FDS (D. Mass.) (Judge F. Dennis Saylor IV). I've chronologized both, since the IPR's entire strategic meaning comes from that case.

2. The petitioner of record was Hamamatsu Corporation, not Unified Patents, Inc. The metadata I was given names Unified Patents as plaintiff/petitioner, but every primary document I retrieved names Hamamatsu Corporation as Petitioner — the Patent Owner's Mandatory Notice (Paper 4), the Board's institution decision (Paper 7), and the Notice of Refund (Paper 11); the National Law Review's PTO Litigation Report for 2017-02-16 also lists "Petitioner – HAMAMATSU CORPORATION." I could not locate any Unified Patents petition against the '467 patent. I have therefore written the chronology around the record as documented and flag the discrepancy rather than reconcile it silently; if the metadata is authoritative for your purposes, treat "Hamamatsu" below as the petitioner of record and "Unified Patents" as a possible co-filer/real-party-in-interest that the public docket does not reflect. Patent Owner's real parties in interest were stated as Harvard (owner) and SiOnyx, LLC (exclusive licensee).

---

Chronological developments

District court phase (the substantive infringement litigation)

Claim construction: I was not able to confirm a Markman ruling or claim-construction order in the sources I reviewed; the Federal Circuit's 2020 opinion and the post-trial opinions discuss validity and infringement without addressing a dispositive construction dispute. Treat "no reported Markman decision" as an absence of evidence, not verified fact.

Discovery milestones: not independently verified in the sources retrieved. The trial record does show the strategically decisive discovery themes: Hamamatsu's internal development report referring to the prototype work (the 2018-02-01 breach date), Hamamatsu's February 2009 Japanese priority filings, and third-party discovery concerning the terminated "Godzilla" business relationship that put SiOnyx on notice of Hamamatsu's patents.

The IPR (the proceeding in your caption)

Grounds the Board rejected (all obviousness): (1) claims 1, 2, 6–8 over the Wu Thesis in view of Gibbons; (2) claims 1, 2, 6–8 over the Wu Article in view of Gibbons; (3) claim 3 over Wu Thesis + Gibbons + Carey; (4) claim 3 over Wu Article + Gibbons + Carey.

Back to the district court: verdict, post-trial, appeal

---

Bottom line and analytical significance

1. The IPR failed outright and therefore had zero estoppel effect. Because the Board denied institution, there was no § 318(a) final written decision, so no § 315(e) estoppel attached to Hamamatsu in the district court. Hamamatsu was free to (and did) run invalidity to the jury — and lost.
2. The petition was filed too late to be useful as a case-management tool. Filed 2017-02-15, denied 2017-09-06, i.e., roughly 18 months before trial and with no stay sought or granted in the sources I reviewed. By the time the rehearing denial issued (2019-09-04), the district court had already entered judgment — the PTAB ruling was moot in every practical sense. The 2019 refund notice closes the file.
3. The denial was merits-based on the motivation-to-combine/expectation-of-success prong — the same vulnerability that surfaced at trial, where the jury rejected Hamamatsu's obviousness case on the '467 patent.
4. The IPR was purely defensive and reactive. It was Hamamatsu's counter-punch to being sued on the '467 patent (the Board expressly notes the patent "is asserted against Petitioner in SiOnyx LLC v. Hamamatsu Photonics K.K."). Its denial meant Hamamatsu had to win validity in front of Judge Saylor's jury — which it did not.
5. The final disposition of the underlying dispute was a plaintiff's win enforced on appeal: validity upheld, willfulness found (unenforceable as to enhancement because damages were $0), plus a permanent injunction on the '467 patent, and — via the § 256/ownership route —

Threshold correction (important)

Before naming counsel, a caption issue needs flagging. The case metadata in this prompt lists Unified Patents, Inc. as the petitioner/plaintiff. That party does not appear anywhere on the IPR2017-00909 docket. Every paper in the proceeding — the petition, the petitioner's power of attorney, the Patent Owner's mandatory notices and power of attorney, the rehearing decision, the refund request, and the Notice of Refund — names Hamamatsu Corporation as Petitioner, and the petition was filed February 15, 2017 by Hamamatsu. See, e.g., Notice of Refund, Paper 11 (Oct. 3, 2019) (caption "HAMAMATSU CORPORATION, Petitioner v. PRESIDENT AND FELLOWS OF HARVARD COLLEGE, Patent Owner"); Decision Denying Request for Rehearing, Paper 9 at 1 (Sept. 4, 2019) (same). The PTAB's own new-filings report for Feb. 16, 2017 likewise lists "Petitioner – HAMAMATSU CORPORATION" for IPR2017-00909, and the Patexia docket sheet is captioned Hamamatsu Corporation v. President & Fellows of Harvard College.

So the "plaintiff-side" party in this case is Hamamatsu, not Unified Patents. I've identified counsel for the actual petitioner below. Unified Patents has no counsel of record here; its usual PTAB team (Roshan Mansinghani, Jonathan Stroud, and WilmerHale's David Cavanaugh/Daniel Williams in 2016–2020-era Unified IPRs) appears in other Unified proceedings but is absent from this docket. I'd recommend correcting the case record; if you need Unified Patents' counsel, that would be a different case.

---

Counsel of record for the petitioner (Hamamatsu Corporation)

All three attorneys are at one firm and all three are carried on every service list in the proceeding.

Sourcing for the roster: Patent Owner's Power of Attorney, Paper 3 at certificate of service (Mar. 1, 2017) (certifying service on "counsel for Petitioner (John D. Simmons, Stephen E. Murray, and Keith A. Jones) … jsimmons@panitchlaw.com … smurray@panitchlaw.com … kjones@panitchlaw.com"); Petitioner's Request for Refund of Post-Institution Fees, Paper 10 at 2 (Sept. 18, 2019) (signed "/John D. Simmons/," listing all three with registration numbers and the Philadelphia address, and signed "Attorney for Petitioners"); Notice of Refund, Paper 11 (Oct. 3, 2019) (PTAB service list to the same three). Docket sheet: https://services.patexia.com/lawsuits/Hamamatsu-Corporation-v-PRESIDENT-%26-FELLOWS-OF-HARVARD-COLLEGE-id-74126/documents .

Caveats and open items

• Lead/back-up designation is an inference, not a direct quote. Paper 1 (Petitioner Power of Attorney) and Paper 2 (Petition) sit behind the Docket Alarm/Patexia download links and I could not open the face of Paper 1 in this session. Simmons is first-named on every filing and did the Federal Circuit argument, which is consistent with lead-counsel designation, but I have not read the § 42.8(b)(3) designation itself. The Board's own decisions don't restate counsel.
• No local counsel, no in-house counsel of record. PTAB practice doesn't use "local counsel," and no Hamamatsu in-house attorney appears on the service lists — only the three Panitch practitioners. This is not a sealing issue; the docket is public and complete (11 papers, 2017–2019).
• Technical/consulting support came from Hamamatsu's expert Dr. Souri (Ex. 1012), not from counsel.
• No pro hac vice motions appear on this docket, so no additional attorneys were admitted ad hoc.

Posture of the representation (for context in your case write-up)

• Petition filed Feb. 15, 2017 (Paper 2), challenging claims 1, 2, 3, and 6–8 of U.S. 8,080,467 over the Wu Thesis/Wu Article in view of Gibbons (and Carey as to claim 3).
• Institution denied on the merits Sept. 6, 2017 (Paper 7) — the Board found the Wu Thesis's annealing taught away; panel was APJs Chang, Bisk, and Harlow.
• Rehearing requested Oct. 6, 2017 (Paper 8); denied Sept. 4, 2019 (Paper 9).
• Post-institution fees refunded ($14,000) Oct. 3, 2019 (Papers 10–11) — the last act in the proceeding.
• Parallel track: the same Panitch team defended Hamamatsu in SiOnyx LLC v. Hamamatsu Photonics K.K. (D. Mass.), where the '467 patent was found valid and willfully infringed (though $0 infringement damages), and won a PTAB ruling invalidating claims of Harvard's related '446 patent in IPR2016-01910 (affirmed, Fed. Cir. Apr. 3, 2019).

I'll research this PTAB proceeding, starting with the docket and any Board decisions.

Key finding already: the docket records differ from the prompt's caption. Let me verify the petitioner and pull the full counsel listing.

Now let me confirm the full counsel list and their professional backgrounds.

Scope note before the names

Two things about the prompt's metadata need flagging, because they affect how you read the counsel list:

1. The petitioner is not Unified Patents. Every primary document in IPR2017-00909 — the Petition (Paper 2), Harvard's Power of Attorney (Paper 3), its Mandatory Notice (Paper 4), and the Board's institution decision (Paper 7) — captions the proceeding Hamamatsu Corporation v. President & Fellows of Harvard College. The National Law Review PTAB petition log for 2/16/2017 also lists Petitioner = Hamamatsu Corporation. I found no Unified Patents filing on this docket. I'm noting this rather than silently overriding your caption, but the counsel records below are keyed to the actual docket.
2. Status nuance: the metadata ("denied on the merits") checks out directionally — Paper 7 (Sept. 6, 2017) is a Decision Denying Institution under § 42.108, not institution (Patexia's docket labels it "Trial Instituted Document," which is a mislabel). Panel: APJs Joni Y. Chang, Jennifer S. Bisk, Jacqueline T. Harlow. Hamamatsu's request for rehearing (Paper 8, Oct. 6, 2017) was denied (Paper 9, Sept. 4, 2019), and the $14,000 post-institution fee was refunded (Paper 11, Oct. 3, 2019).

The "defendant" here is the patent owner, President & Fellows of Harvard College ('467 patent, "Silicon-Based Visible and Near-Infrared Optoelectric Devices" — the "black silicon" family).

Counsel of record for the Patent Owner (Harvard)

Sources: Paper 3 (PO Power of Attorney, filed Mar. 1, 2017) and Paper 4 (PO Mandatory Notice, Mar. 1, 2017), both served on petitioner's counsel Panitch Schwarze; Paper 11 (Notice of Refund) repeats "PATENT OWNER: Thomas Engellenner … Reza Mollaaghababa."

Attorney notes

Thomas J. Engellenner — lead counsel

• Then a partner in Pepper Hamilton's Boston IP department; moved to Nelson Mullins Riley & Scarborough LLP (Boston) in March 2019 with Mollaaghababa, where he is still listed; more recently also identified as principal of Engellenner Law.
• 40+ years in patent prosecution and litigation; former trial attorney for the U.S. EPA, former in-house patent/licensing attorney at MIT's Technology Licensing Office; former President of the Boston Patent Law Association. Martindale lists him as co-chair of a life sciences practice group.
• Deep PTAB bench: his own 2013 pro hac vice declaration describes "over 30 years" of prosecution/litigation, and his 2019 lateral-announcement bio credits him and Mollaaghababa with more than 80 IPRs combined. He was Harvard's designated lead in sister Harvard IPRs as well (e.g., IPR2017-00663 on U.S. 8,334,016), and was the long-time outside PTAB counsel for Harvard/SiOnyx in the underlying black-silicon dispute.

Reza Mollaaghababa, Ph.D. — back-up counsel

• Pepper Hamilton (Boston) partner at the time; joined Nelson Mullins with Engellenner in March 2019. Ph.D. scientist-turned-patent litigator; same 80+ IPR post-grant practice profile, with optics/photonics-adjacent prosecution work for Harvard and SiOnyx.
• Note his name is spelled inconsistently across the served papers ("Mollaaghababa" in the POA/caption vs. "mollaaghababar" in one e-mail field); "Mollaaghababa" is the correct form.

Karen A. Sinclair — in-house

• Signed the Power of Attorney for Harvard as Director of Intellectual Property, Harvard OTD. She is the client representative of record, not an appearing PTAB attorney; no separate in-house appearance or argument on the docket.

Appearances, changes, and sealing

• No updated mandatory notices appear on this docket — papers run 1–11 and end with the 2019 refund notice. So the Mar. 1, 2017 designation (Engellenner lead / Mollaaghababa back-up) is the only counsel designation ever filed; it was never amended despite the Sept. 2017 institution denial and the two-year gap before rehearing was decided.
• No sealed filings. The Petition, POPR, POA, Mandatory Notice, institution decision and rehearing papers are all public in PTAB E2E / Docket Alarm.
• No separate "local counsel" — normal for PTAB; Pepper Hamilton's Boston office served as both lead and backup.
• Real parties in interest for the patent owner: Harvard and SiOnyx, LLC as exclusive licensee (Paper 4, citing § 42.8(b)(1)). SiOnyx's parent CF Sion, LLC was disclosed. Notwithstanding that, no separate SiOnyx counsel entered an appearance in this IPR — Harvard's Pepper Hamilton team carried it. Notably, in the parallel D. Mass. case and the resulting Federal Circuit appeal (SiOnyx LLC v. Hamamatsu Photonics K.K., No. 2019-2359, decided Dec. 7, 2020), the plaintiffs' appellate counsel of record was William D. Belanger of Troutman Pepper Hamilton Sanders — i.e., the firm formed when Pepper Hamilton combined with Troutman Sanders in 2020. That is a different forum and a different appearance line; don't conflate Belanger with the PTAB record here.

For contrast — petitioner's counsel (Hamamatsu)

All of Panitch Schwarze Belisario & Nadel LLP (Philadelphia): John D. Simmons (lead), Stephen E. Murray, and Keith A. Jones. Simmons is also Hamamatsu's counsel of record in the parallel district court and Federal Circuit litigation. Not asked, but useful because it's who Harvard's team was serving papers on.

Sourcing caveats

• Counsel identification rests on the served PTAB papers (Papers 3, 4, 11) retrieved via Docket Alarm and cross-checked against the Patexia docket index; I did not independently pull the PTAB E2E docket sheet, so if PTAB E2E shows a counsel update I did not retrieve, that would supersede this.
• Mollaaghababa's registration number and his exact current title at Nelson Mullins are unverified; the OCR of the served copies cut the number off, and I did not obtain a firm bio page for him before running out of search budget. Treat that field as an open item rather than filling it in.
• Engellenner's current status is reported inconsistently by third-party sources (Nelson Mullins profile and IPWatchdog bio vs. an AIPLA speaker listing under "Engellenner Law"); the 2017-era affiliation (Pepper Hamilton, Boston) is the one that matters for this proceeding and is documented in the filings.